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ABSTRACT
Objective: This study was to investigate the effect of Physalis angulata L. leaf water extract on vascular rarefaction, oxidative stress, and inflammation 
on the kidney of Nω-nitro-L-arginine methyl ester (L-NAME)-induced male Wistar rats.
Methods: A total of 25 male Wistar rats were divided into five equal groups (normal control: 40 mg/kg/day of normal saline; L-NAME group; and treatments I, 
II, and III: L-NAME plus P. angulata L. leaf water extract doses 500 mg/kg/day, 1500 mg/kg/day, and 2500 mg/kg/day, respectively). Endothelial dysfunction 
was induced by 40 mg/kg/day L-NAME intraperitoneally. The treatment lasts for 15 days. Vascular rarefaction was indicated by the decrease in vascular 
density, which considered as vascular number per high-power field in hematoxylin-eosin staining preparation. Kidney oxidative stress test was performed 
by measuring malondialdehyde (MDA) level with thiobarbituric acid reactive substances assay. The inflammatory marker was the nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) expression which examined using an immunohistochemical method with an antibody against p65.
Results: At the dose of 500 mg/kg/day and 1500 mg/kg/day, P. angulata leaf water extract supplementation increased the vascular density, decreased 
the MDA level, and decreased the NF-κB expression compared to the L-NAME group.
Conclusion: The administration of P. angulata L. leaf water extract in particular concentration has a vasoprotective effect by preventing kidney 
vascular rarefaction, oxidative stress, and inflammation on L-NAME-induced male Wistar rat.
Keywords: Endothelial dysfunction, Kidney, Malondialdehyde, Nuclear factor kappa-light-chain-enhancer of activated B cells, Nω-nitro-L-arginine 
methyl ester, Physalis angulata leaf, Vasoprotective.
INTRODUCTION
Endothelial dysfunction is indicated by the decreased bioavailability 
of vasodilators, primarily nitric oxide (NO) [1,2]. In the kidney, NO has 
various important functions, such as regulation of renal hemodynamics, 
regulation of glomerular microcirculation and salt balance, blunting of 
tubuloglomerular feedback, and modulation of renal sympathetic nerve 
activity [3,4]. The inhibition of NO synthesis by Nω-nitro-L-arginine 
methyl ester (L-NAME) in rats leads to endothelial vasoconstriction 
and activation indicated by pro-inflammatory, proliferative, and 
procoagulant conditions [4,5]. It results in severe hypertension and 
causes kidney damage [3,4].
Endothelial dysfunction creates an imbalance between NO and reactive 
oxygen species (ROS) which leads to oxidative stress [6]. ROS can attack 
various biomolecular components of the cells, such as lipid, which causes 
lipid peroxidation (LPO). This reaction released LPO products, such as 
malondialdehyde (MDA) [3]. ROS also activates one of the transcription 
factors, such as nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-κB), which will subsequently induce the synthesis of 
inflammatory mediators, and vice versa [7]. Excessive NF-κB activation 
leads to excessive inflammation and cell damage [8]. The damaged 
kidney vascular cells lead to structural changes called renal vascular 
rarefaction indicated by the decrease in vascular density [9,10]. Kidney 
capillary rarefaction is associated with aging and renal fibrosis and is an 
indicator of impaired renal function [11]. Therefore, preventing kidney 
vascular rarefaction, oxidative stress, and inflammation is important in 
the management of endothelial dysfunction associated kidney diseases.
Ciplukan (Physalis angulata L.) leaf is known to have high 
antioxidant effects in vitro [12]. The previous study proved that 
P. angulata leaf extract contains Physalin, a class of secosteroids. 
This compound could increase the release of NO from endothelial 
cell in vitro. This increase of NO release is thought to occur through 
genomic effects by increasing the expression of endothelial NO 
synthase (eNOS) and inducible NO synthase and non-genomic 
effects by increasing cytosolic calcium [13]. Another study proved 
the target of P. angulata leaf water extract in NO synthesis pathway 
through increased levels of vascular endothelial growth factor 
(VEGF) and eNOS [14].
The objective of this study is to investigate the effects of P. angulata L. 
leaf water extract, which contains physalin, withanolides [13,15,16], 
and flavonoid [17] on vascular rarefaction, oxidative stress, and 
inflammation in the kidney of NOS-inhibited Wistar rats by L-NAME.
METHODS
Animal preparation
A total of 25 male Wistar rats, weighing 250–300 g, were placed in 
a quiet room with cage temperature 21±2°C, in which a 12–12 h 
light-dark cycle was maintained. They were fed and watered by ad 
libitum. After 7 days of acclimatization, Wistar rats were divided 
into five groups (control negative: normal saline 0.9%, i.p; L-NAME 
group: 40 mg/kg/day L-NAME i.p; and L-NAME 40 mg/kg/day, i.p. + 
P. angulata leaf water extract doses of 500, 1500, and 2500 mg/kg/day 
by gavage, respectively). The treatment lasts for 15 days [3,18,19]. 
The dose of water extract of P. angulata leaves was determined based 
on the previous study [20]. The procedures were approved by the 
Health Research Ethics Committee of Brawijaya University (No.114/
EC/KEPK/03/2017).
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Extract preparation
P. angulata leaves were obtained from Balai Penelitian Tanaman 
Obat dan Rempah, Lembang, Indonesia. The sample of the herbs was 
determined and confirmed as P. angulata species by the Laboratory of 
School of Life Sciences and Technology, Bandung Institute of Technology, 
Indonesia. As much as 10 g of P. angulata leaves dry powder were 
soaked in 100 ml of boiled water for an hour. The solution was filtered 
from the precipitated product by cotton cloth to obtain 80 ml thick 
extract. The same process was repeated for the remaining product. It 
was soaked again in 30 ml boiled water for an hour and then filtered 
to obtain 20 ml extract. From this procedure, we got 100 ml P. angulata 
leaf extract with a concentration of 10% (w/v).
Determination of MDA level
Kidney LPO was used as an indicator of oxidative stress [21]. It was 
measured according to the concentration of thiobarbituric acid (TBA) 
reactive substances. The amount of produced MDA was used as an 
index of LPO [22]. MDA and TBA react and produce pink pigment with 
a maximum absorption at 535 nm [23]. Tissue homogenate (0.1 ml) 
was mixed with 2 ml reagent consisting of 0.37% TBA, 0.25 N HCl, 
and 15% trichloroacetic acid with 1:1:1 ratio. The mixture was then 
placed in a boiling water bath for 15 min. After cooling, the mixture 
was centrifuged at room temperature for 10 min and the absorbance of 
the clear supernatant was read at 535 nm [24]. Data were expressed as 
nm/300 mg tissue.
Immunohistochemical preparation and evaluation
At the end of the experimental period, the rat kidneys were removed, 
fixed in 10% buffered formalin solution, and then embedded in paraffin. 
Each kidney was cut in a sagittal section into two halves. Paraffin 
kidney sections (5 mm) were prepared for immunohistochemical 
examination, and another was stained with hematoxylin and eosin. 
For immunohistochemical analysis of NF-κB, antigen unmasking was 
performed by heating the sections in citrate buffer, pH 6.0, using a 
water bath 95°C for 20 min. Sections were incubated overnight with 
primary antibodies (1:100 polyclonal p65, Santa Cruz Biotechnology) 
at 4°C. The detection of immunopositive cells used the avidin-biotin-
peroxidase complex method. Immunoreactivity was visualized with 
diaminobenzidine. Hematoxylin was used as the counterstain. Negative 
controls consisted of each case in which the primary antibody was 
omitted.
Renal sections were scored for the presence of p65 in renal cells, 
whether in the cytoplasm or in the nucleus. Renal cells were 
quantitatively measured by counting at least 20 randomly selected 
high-power fields (×400) in the cortex and outer medulla area. The final 
score obtained was expressed as the number of positive cells per high-
power fields [25].
Histopathological evaluation
The vascular density of the kidneys was evaluated by counting the 
vascular in 20 randomly selected field sites in the renal cortex and outer 
medulla with a magnification of ×400. It will be considered as vascular 
if there is a lumen containing erythrocytes and coated by endothelial 
cell(s) [26]. Data were expressed as the number of vascular per high-
power field.
Statistical analysis
The data were analyzed with SPSS 23.0 for Windows using independent 
t-test to compare the control and L-NAME group. One-way analysis of 
variance was used to compare the L-NAME group and the treatment 
groups. Differences between group were determined using post hoc 
analysis in which the significance level was described as p<0.05.
RESULTS
The L-NAME effect on vascular density, MDA levels, and NF-κB 
expression in rat kidney
The effects of L-NAME on vascular density, MDA levels, and NF-κB 
expression in rat kidney are shown in Fig. 1a-c, respectively. L-NAME 
tended to decrease the vascular density in rat kidney compared to the 
control group, but it was not statistically significant, while the MDA 
level and NF-κB expression tended to increase in the L-NAME group 
compared to the control group, but it was not significantly different.
The effect of P. angulata leaf water extract on kidney vascular 
density
Administration of P. angulata leaf water extract at dose 
1 (500 mg/kg/day) and dose 2 (1500 mg/kg/day) could increase 
vascular number significantly to L-NAME group. Increasing the dose of 
P. angulata leaf water extract tended to decrease the vascular number 
in renal cortex compared to dose 1 (500 mg/kg/day). At dose 3 
(2500 mg/kg/day), there was significant decrease on vascular number 
compared to dose 1 (500 mg/kg/day) but not significant to dose 2 
(1500 mg/kg/day) (Figs. 2 and 3).
The effect of P. angulata leaf water extract on kidney MDA level
MDA level is an important indicator of oxidant status. The data of MDA 
level in L-NAME plus P. angulata leaf water extract with various dose 
groups are indicated in Fig. 4. There was a decrease in MDA level of 
P. angulata leaf water extract at dose 1 of 500 mg/kg/day compared 
to L-NAME group. Increasing the dose of the P. angulata leaf extract at 
dose 2 (1500 mg/kg/day) and 2500 mg/kg/day tended to increase the 
MDA level compared to the lowest dose (Fig. 4).
The effect of P. angulata leaf water extract on NF-κB p65 expression
The effect of L-NAME and P. angulata leaf water extract on NF-kB 
expression is shown in Fig. 5. It was shown that the administration of 
500 mg/kg/day (dose 1) P. angulata leaf water extract tends to decrease 
p65 expression on rat kidney, but it was not significant. Administration 
of P. angulata leaf water extract at higher doses (doses 2 and 3) tends 
to increase p65 NF-κB expression compared to dose 1 (Figs. 5 and 6).
DISCUSSION
This study showed that the vascular density in the renal cortex 
was decreased after 15 days of L-NAME induction followed by the 
increasing level of MDA and NF-κB expression (Fig. 1). It was in 
accordance with the previous studies, showing that L-NAME may 
cause endothelial dysfunction by lowering NO which promotes 
thrombosis, vasospasm, vascular inflammation, and proliferation of 
vascular smooth muscle cells [1]. Oxidative stress also contributes 
to the mechanisms of endothelial dysfunction. L-NAME may increase 
oxidative stress by enhancing nicotinamide adenine dinucleotide 
phosphate oxidase expression [27,28]. Cell membranes composed of 
poly-unsaturated fatty acids are particularly susceptible to oxidative 
attack, which resulted in the changes of permeability, membrane 
fluidity, and cellular metabolic functions. MDA, one of the LPO products, 
was found to increase in oxidative stress state [21]. L-NAME can induce 
inflammation and kidney damage by increasing angiotensin (AT) 2 
stimulation to AT1-receptor [29] so that it activates the transcription 
factor NF-κB [30]. These processes finally will lead to microvascular 
rarefaction [9,31], which was indicated by a decreased in vascular 
density [10].
The insignificant result of all three variables in the L-NAME group 
compared to the control group can be caused by a relatively short 
duration of treatment and/or less L-NAME dose being used. A study by 
Cipolla et al. [32] showed that it took 5 weeks of L-NAME administration 
at a dose of 0.5 g/L drinking water to cause loss of vascular (rarefaction) 
structures in the Sprague-Dawley rat brain capillaries. Meanwhile, 
the other studies were performed for 7–8 weeks to make significant 
renal damage and inflammation [4,33-36]. The other needed 28 days 
to significantly increase rat kidney MDA level [37-39]. These studies 
indicate that the kidney needs a longer duration than 15 days of 
L-NAME administration to significantly decrease the vascular density 
and increase the MDA level as well as the NF-κB expression. Kidney 
endurance may contribute to this phenomenon. The kidney can 
protect itself from L-NAME-induced hypertension by its autoregulation 
mechanism. This autoregulation mechanism causes kidney blood 
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pressure to be maintained normally despite an increase in systemic 
blood pressure [40].
Moreover, kidney cells can protect themselves from oxidative stress 
by synthesizing antioxidant enzymes. A study mentioned that renal 
ischemia would increase renal antioxidant enzymes [41]. This study 
showed that MDA levels in the L-NAME group did not increase 
significantly at the end of the treatment (Fig. 1b). It indicates that the 
antioxidant enzymes can still compensate for the free radical generated 
by L-NAME induction. Furthermore, AT2 also plays a role in kidney 
endurance [42]. The balance of AT2 effects on AT1 and AT2 receptors 
has an important impact on inducing kidney injury due to L-NAME 
administration. AT2 stimulation to AT1-receptor induces pro-oxidant 
and pro-inflammatory effects [43]. Meanwhile, AT2 stimulation to AT2-
receptor counteracts those effects [44]. AT2-receptor stimulation can 
increase NO levels [45], possibly through direct stimulation of NOS 
Fig. 2: Mean of kidney cortex vascular density. *p<0.05 compared 
to the Nω-nitro-L-arginine methyl ester (L-NAME) group.#p<0.05 
compared to L-NAME + Physalis angulata dose 3. Data were 
analyzed using analysis of variance and post hoc test
Fig. 4: Mean of kidney malondialdehyde level. Data were analyzed 
using the analysis of variance test and post hoc test
Fig. 5: Mean of p65-positive renal cells. Data were analyzed using 
the analysis of variance test and post hoc test. *p<0.05 compared 
to Nω-nitro-L-arginine methyl ester + dose 3 group
Fig. 1: Mean of vascular density (a), mean of malondialdehyde 
level (b), and mean of p65 expression (c) control (without 
Nω-nitro-L-arginine methyl ester [L-NAME]) and L-NAME 
(40 mg/kg/day). Data were presented as mean ± standard error 
of the mean and analyzed using independent t-test
a b c
Fig. 3: Kidney cortex of negative control group (a), Nω-nitro-L-
arginine methyl ester (L-NAME) group (b), L-NAME+extract dose 1 
group (c), L-NAME + extract dose 2 group (d), L-NAME + extract 
dose 3 group (e). The red arrow indicates vascular. HE, ×400, 






Fig. 6: Kidney p65 nuclear factor kappa light chain enhancer of 
activated B cells expression of the negative control group (a), 
Nω-nitro-L-arginine methyl ester (L-NAME) group (b), and L-NAME 
+ extract dose 1 group (c), L-NAME + extract dose 2 group (d), 
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and bradykinin pathway [46]. The AT2-receptor stimulation reduces 
inflammatory response through JAK/STAT inhibition, NF-κB inhibition, 
and COX2 synthesis inhibition [47]. Therefore, in this study, we 
assumed that the reduction of NO levels induced by L-NAME still can 
be compensated by AT2 stimulation to AT2-receptor. Thus, the vascular 
density in the L-NAME group decreases insignificantly, following 
MDA level and NF-κB expression which increase insignificantly when 
compared to the control group (Fig. 1a-c).
Ciplukan (P. angulata) was reported as an important herbal medicine in 
the Indian Traditional System of Medicine [15,16]. Qualitative analysis 
of the content of P. angulata leaf water extract and ethanol extract found 
the presence of flavonoids, saponins, terpenoids, polyphenols, tannins, 
alkaloids, and steroids [48,49]. Our result showed that the treatment 
groups receiving 500 mg/kg/day and 1500 mg/kg/day P. angulata 
leaf water extract had significantly higher vascular density compared 
to the L-NAME group (Figs. 2 and 3). Therefore, it can be assumed 
that supplementation of P. angulata leaf water extract can prevent 
L-NAME-induced vascular rarefaction. This result is in accordance 
with a previous study, showing that P. angulata could increase NO 
level of endothelial cell culture [13]. NO has a vasoprotective effect by 
preventing endothelial cell apoptosis [50] and by inhibiting caspase 
through S-nitrosylation of cysteine residues [51]. Adequate NO 
level promotes neovascularization, one of which through the VEGF 
pathway and fibroblast growth factor [52]. NO stimulates endothelial 
migration by inducing endothelial cell podokinesis, increasing the 
expression of αvβ3, and enhancing dissolution of the extracellular 
matrix through the fibroblast growth factor-induced upregulation of 
urokinase-type plasminogen activator [53]. Furthermore, NO may 
suppress the production of angiostatin, an endogenous antagonist of 
angiogenesis [54]. Sulistyowati also proved that the effect of Ciplukan 
(P. angulata L.) water extract on NO synthesis pathway was by 
increasing VEGF levels [14]. VEGF was known as a substance needs to 
promote vascularization [52,55].
P. angulata leaf water extract has a high antioxidant effect 
in vitro [12, 16]. This might be due to the flavonoid content of 
P. angulata which are 5-Methoxy-6,7-methylenedioxyflavone and 
5,6,7-trimethoxyflavone [56]. Flavonoids prevent tissue damage from 
free radicals through various mechanisms. First, it reacts with free 
radical molecules directly because the flavonoids have hydroxyl groups 
with high reactivity. Second, it inhibits xanthine oxidase to prevent 
superoxide formation when reoxygenation occurs [57]. In accordance 
with those previous studies, the addition of 500 mg/kg/day and 
1500 mg/kg/day P. angulata leaf water extract was able to lower the 
MDA level of L-NAME-induced Wistar rat (Fig. 4). Therefore, it can be 
assumed that supplementation of P. angulata leaf water extract can 
prevent oxidative stress in the kidney of endothelial dysfunction Wistar 
rat model.
Treatment with P. angulata leaf water extract at a dose of 
500 mg/kg/day and 1500 mg/kg/day also decreased p65 NF-κB 
expression (Figs. 5 and 6). The previous study reported that P. angulata 
leaves have anti-inflammatory effects through tumor necrosis factor-α 
(TNF-α) inhibition [16,20]. It was known that TNF-α can trigger the 
classic pathway of NF-κB activation, resulting in an inflammatory 
response. This is reinforced by the research of Grumbach et al. [58], 
stating that NO can inhibit NF-κB activation in vitro. NF-κB activation 
will be manifested as a total increase in the expression of p65 
proteins of the NF-κB complex [59]. The interesting result from the 
immunohistochemistry analysis above is that the p65 expression is 
never found in glomerular cells (Fig. 6). It indicates the involvement of 
glomerular autoregulation mechanism which protects the glomerulus 
from L-NAME-induced inflammation. Despite the changes in renal 
perfusion pressure, the autoregulatory mechanism keeps the renal 
blood flow and glomerular filtration rate constant [40].
Ciplukan (P. angulata) leaves have a unique characteristic. At 
lower dose (500 and 1500 mg/kg/day), it serves as proangiogenic, 
antioxidant, and anti-inflammatory substance. Conversely, at high dose 
(2500 mg/kg/day), it showed to decrease vascular density (Fig. 2), 
increase MDA level (Fig. 4), and increase NF-κB expression (Fig. 5). It 
indicates that there was an excessive NO formation induced by high-
dose administration of P. angulata leaf water extract. This finding 
was in accordance with the previous study, showing that high NO 
concentration could promote endothelial cell damage [60,61]. NO 
cytotoxic effect is related to the chemical reactivity of peroxynitrite 
(ONOO−) formed from NO [62]. ONOO− caused persistent activation 
of NF-κB [63]. Conversely, the cytoprotective action of NO is attributed 
to the inhibition of NF-κB-mediated gene expression which produces 
ubiquitous anti-inflammatory activity [62]. The molecular mechanisms 
underlying the proapoptotic effect of high-dose NO remain speculative. 
The factors determining whether endothelial cells undergo apoptosis 
when exposed to NO include the amounts of NO, the different redox 
states of NO, and the local environment that may promote the further 
production of cytotoxic moieties such as ONOO−. The previous study 
showed that NO and ONOO− can damage DNA directly. The damaged 
DNA triggers the p53-dependent or p53-independent apoptotic cell 
death pathways which furthermore activates caspases [60]. The 
damaged cells are not able to synthesize VEGF again [31]. Finally, the 
decrease in VEGF led to vascular rarefaction [64].
Moreover, exogenous antioxidants can act as a double-edged sword, 
becoming antioxidant at low doses and prooxidant at high doses [65,66]. 
Therefore, increasing P. angulata leaf water extract dose will probably 
increase the antioxidant which reacts as a prooxidant. Another study 
by Nnamani et al. [67] reported that P. angulata leaves contain cyanide. 
Cyanide can cause oxidative stress in cells resulting in cell death [68,69]. 
Therefore, we hypothesized that a high concentration of P. angulata leaf 
water extract has a contrary effect, which is antiangiogenic, pro-oxidant, 
and pro-inflammatory. We also hypothesized that the high MDA level of 
the treatment group receiving 2500 mg/kg/day P. angulata leaf water 
extract might be caused by the effect of cyanide which becomes more 
dominant.
CONCLUSION
Based on those results, we concluded that the administration of 
P. angulata L. leaf water extract in particular concentrations has 
a vasoprotective effect by preventing kidney vascular rarefaction, 
oxidative stress, and inflammation on L-NAME-induced male Wistar 
rat. This study implies the importance of the optimal dose of P. angulata 
leaf water extract supplementation for the prevention of endothelial 
dysfunction-induced kidney injury. However, vascular rarefaction 
pathway is not only triggered by NF-κB and oxidative stress but also 
triggered by several pathways such as VEGF and proapoptotic signaling 
for vascular rarefaction. To investigate this pathway, further studies are 
needed.
ACKNOWLEDGMENT
This research was supported by grants from The Ministry of Research, 
Technology, and Higher Education of the Republic of Indonesia through 
INSINAS 2016 funding program.
AUTHOR CONTRIBUTION
All the authors have the same contribution in this research (carried out 
the research, collected the data, analyzed the data, and formatted the 
manuscript).
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
 REFERENCES
1. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc 
Nephrol 2004;15:1983-92.
2. Förstermann U. Nitric oxide and oxidative stress in vascular disease. 
Pflugers Arch 2010;459:923-39.
436
Asian J Pharm Clin Res, Vol 12, Issue 1, 2019, 432-437
 Febianti et al. 
3. Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: 
Cardiovascular risk factors, therapy, and outcome. Vasc Health Risk 
Manag 2005;1:183-98.
4. Higashi Y, Maruhashi T, Noma K, Kihara Y. Oxidative stress and 
endothelial dysfunction: Clinical evidence and therapeutic implications. 
Trends Cardiovasc Med 2014;24:165-9.
5. Talas ZS, Ozdemir I, Ciftci O, Cakir O, Gulhan MF, Pasaoglu OM, 
et al. Role of propolis on biochemical parameters in kidney and heart 
tissues against L-NAME induced oxidative injury in rats. Clin Exp 
Hypertens 2014;36:492-6.
6. Tsuchiya K, Tomita S, Ishizawa K, Abe S, Ikeda Y, Kihira Y, et al. Dietary 
nitrite ameliorates renal injury in L-NAME-induced hypertensive rats. 
Nitric Oxide 2010;22:98-103.
7. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors 
and its regulation. Cold Spring Harb Perspect Biol 2009;1:a000034.
8. Guzik TJ, Harrison DG. Endothelial NF-kappaB as a mediator of 
kidney damage: The missing link between systemic vascular and renal 
disease? Circ Res 2007;101:227-9.
9. Goligorsky MS. Pathogenesis of endothelial cell dysfunction in chronic 
kidney disease: A retrospective and what the future may hold. Kidney 
Res Clin Pract 2015;34:76-82.
10. Olufsen MS, Hill NA, Vaughan GD, Sainsbury C, Johnson M. 
Rarefaction and blood pressure in systemic and pulmonary arteries. J 
Fluid Mech 2012;705:280-305.
11. Schmitt R, Melk A. Molecular mechanisms of renal aging. Kidney Int 
2017;92:569-79.
12. Kusumaningtyas RW, Lailya N, Limandha P. Potential of Ciplukan 
(Physalis angulata L.) as source of functional ingredient. Procedia 
Chem 2015;14:367-72.
13. Nurdiana PN, Karyono S. Efek non genomik dan genomik ekstrak 
daun ceplukan (Physalis minima L) pada kultur sel endotel manusia 
(HUVECs). J Ilmu Ilmu Hayati 2010;22:14-9.
14. Sulistiyowati Y. Sasaran Aksi Ekstrak Air Herba Ciplukan (Physalis 
angulata L) Terstandar Fisalin pada Jalur Sintesis Nitric Oxide 
Tikus Sprague Dawley Diinduksi Nicotinamide Dan Streptozotocin. 
Disertasi, Universitas Gadjah Mada; 2015.
15. Chothani DL, Vaghasiya HU. A phyto-pharmacological overview on 
Physalis minima Linn. Indian J Nat Prod Resour 2012;3:477-82.
16. Sharma N, Bano A, Dhaliwal HS, Sharma V. A pharmacological 
comprehensive review on ‘rassbhary’ Physalis angulata (L.). Int J 
Pharm Pharm Sci 1987;7:30-4.
17. Susanti RF, Kurnia K, Vania A, Reynaldo IJ. Total phenol, flavonoid and 
antioxidant activity of Physalis angulata leaves extract by subcritical 
water extraction. Mod Appl Sci 2015;9:190-8.
18. Talas ZS, Ozdemir I, Ciftci O, Cakir O. Propolis attenuates oxidative 
injury in brain and lung of nitric oxide synthase inhibited rats. J Pharm 
Care 2013;1:45-50.
19. Selamoglu ZS, Ozdemir I, Ciftci O, Gulhan MF, Savci A. Antioxidant 
effect of ethanolic extract of propolis in liver of L-NAME treated rats. 
Adv Clin Exp Med 2015;24:227-32.
20. Lestari B, Permatasari N, Rohman MS. Methanolic extract of ceplukan 
leaf (Physalis minima L.) attenuates ventricular fibrosis through 
inhibition of TNF-α in ovariectomized rats. Adv Pharmacol Sci 
2016;2016:2428052.
21. Gaweł S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) 
as a lipid peroxidation marker. Wiad Lek 2004;57:453-5.
22. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: Production, 
metabolism, and signaling mechanisms of malondialdehyde and 
4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014;2014:31.
23. Grotto D, Maria LS, Valentini J, Paniz C, Garcia GS, Rocha JB, et al. 
Importance of the lipid peroxidation biomarkers and methodological 
aspects for malondialdehyde quantification. Quim Nova 2009;32: 
169-74.
24. Ganie SA, Haq E, Hamid A, Qurishi Y, Mahmood Z, Zargar BA, et al. 
Carbon tetrachloride induced kidney and lung tissue damages and 
antioxidant activities of the aqueous rhizome extract of Podophyllum 
hexandrum. BMC Complement Altern Med 2011;11:17.
25. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, 
Guiba-Tziampiri O, et al. Erythropoietin attenuates renal injury in 
experimental acute renal failure ischaemic/reperfusion model. Nephrol 
Dial Transplant 2006;21:330-6.
26. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. 
Neovascularization in human atherosclerosis. Circulation 
2006;113:2245-52.
27. Zabrecky A, Pham H, Koon A, Rueter B, Barsotti R, Young L, et al. 
The role of NADPH oxidase isoform 1 (NOX1) in L-NAME-induced 
leukocyte-endothelial interactions in rat mesenteric postcapillary 
venules (Abstract). FASEB J 2016;30 Suppl:723-2.
28. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, et al. Expression 
of a functionally active gp91phox-containing neutrophil-type NAD(P)
H oxidase in smooth muscle cells from human resistance arteries: 
Regulation by angiotensin II. Circ Res 2002;90:1205-13.
29. Figueroa-Guillén ES, Castro-Moreno P, Rivera-Jardón FF, Gallardo-
Ortiz IA, Ibarra-Barajas M, Godínez-Hernández D, et al. Angiotensin II 
pressor response in the L-NAME-induced hypertensive pithed rat: Role 
of the AT1 receptor. Proc West Pharmacol Soc 2009;52:54-6.
30. Crowley SD. Linking angiotensin II to nuclear factor-κ light chain 
enhancer of activated B cells-induced cardiovascular damage: Bad 
CARMAs. Hypertension 2014;64:933-4.
31. Chade AR. Renal vascular structure and rarefaction. Compr Physiol 
2013;3:817-31.
32. Cipolla MJ, Bishop N, Vinke RS, Godfrey JA. PPAR{gamma} 
activation prevents hypertensive remodeling of cerebral arteries and 
improves vascular function in female rats. Stroke 2010;41:1266-70.
33. Pechanova O, Barta A, Vrankova S. The role of nuclear factor kappa B 
in L-NAME-induced hypertension. J Hypertens 2010;28:491-2.
34. Peeri M, Habibian M, Azarbayjani MA, Hedayati M. Protective effect 
of aerobic exercise against L-NAME-induced kidney damage in rats. 
Arh Hig Rada Toksikol 2013;64:43-9.
35. Vrankova S, Parohova J, Barta A, Janega P, Simko F, Pechanova O, 
et al. Effect of nuclear factor kappa B inhibition on L-NAME-induced 
hypertension and cardiovascular remodelling. J Hypertens 2010;28 
Suppl 1:S45-9.
36. Gonzalez W, Fontaine V, Pueyo ME, Laquay N, Messika-Zeitoun D, 
Philippe M, et al. Molecular plasticity of vascular wall during N(G)-
nitro-L-arginine methyl ester-induced hypertension: Modulation of 
proinflammatory signals. Hypertension 2000;36:103-9.
37. Abd-Eldayem AM, Farghaly HS, Abdel-Zaher AO. The nephroprotective 
effects of Ginkgo biloba extract (EGb761) against l-NG-nitroarginine 
methyl ester-induced hypertension in rats: Role of oxidative stress and 
inflammatory markers. J Curr Med Res Pract 2016;1:79-85.
38. Valentine TM, Charles FN, Estella TA, Mauricette MA, Anatole AE, 
Julius OE, et al. Hydroethanolic extract of Eribromao blongum 
(Malvaceae) stem bark prevents hypertension, oxidative stress and 
dyslipidemia in L-NAME induced hypertension in wistar rats. J Dis 
Med Plants 2016;2:43.
39. Khattab M, Ahmad M, Al-Shabanah OA, Raza M. Effects of losartan 
on blood pressure, oxidative stress, and nitrate/nitrite levels in the nitric 
oxide deficient hypertensive rats. Receptors Channels 2004;10:147-57.
40. Carlström M, Wilcox CS, Arendshorst WJ. Renal autoregulation in 
health and disease. Physiol Rev 2015;95:405-511.
41. Singh I, Gulati S, Orak JK, Singh AK. Expression of antioxidant 
enzymes in rat kidney during ischemia-reperfusion injury. Mol Cell 
Biochem 1993;125:97-104.
42. Peluso AA, Santos RA, Unger T, Steckelings UM. The angiotensin Type 
2 receptor and the kidney. Curr Opin Nephrol Hypertens 2017;26:36-42.
43. Sohn HY, Raff U, Hoffmann A, Gloe T, Heermeier K, Galle J, et al. 
Differential role of angiotensin II receptor subtypes on endothelial 
superoxide formation. Br J Pharmacol 2000;131:667-72.
44. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, 
et al. Effects of ANG II Type 1 and 2 receptors on oxidative stress, 
renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr 
Comp Physiol 2003;285:R117-24.
45. Matavelli LC, Huang J, Siragy HM. Angiotensin AT2 receptor 
stimulation inhibits early renal inflammation in renovascular 
hypertension. Hypertension 2011;57:308-13.
46. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, et al. 
Identification and characterization of a functional mitochondrial 
angiotensin system. Proc Natl Acad Sci U S A 2011;108:14849-54.
47. Kaschina E, Namsolleck P, Unger T. AT2 receptors in cardiovascular 
and renal diseases. Pharmacol Res 2017;125:39-47.
48. Karpagasundari C, Kulothungan S. Free radical scavenging activity 
of Physalis minima Linn. leaf extract (PMLE). J Med Plants Stud 
2014;2:59-64.
49. Patel T, Shah K, Jiwan K, Shrivastava N. Study on the antibacterial 
potential of Physalis minima Linn. Indian J Pharm Sci 2011;73:111-5.
50. Yamashita T, Yamamoto E, Kataoka K, Nakamura T, Matsuba S, 
Tokutomi Y, et al. Apoptosis signal-regulating kinase-1 is involved 
in vascular endothelial and cardiac remodeling caused by nitric oxide 
deficiency. Hypertension 2007;50:519-24.
51. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and 
vessel regression. Circ Res 2000;87:434-9.
52. Dulak J, Józkowicz A, Dembinska-Kiec A, Guevara I, Zdzienicka A, 
Zmudzinska-Grochot D, et al. Nitric oxide induces the synthesis of 
437
Asian J Pharm Clin Res, Vol 12, Issue 1, 2019, 432-437
 Febianti et al. 
vascular endothelial growth factor by rat vascular smooth muscle cells. 
Arterioscler Thromb Vasc Biol 2000;20:659-66.
53. Cooke JP, Losordo DW. Nitric oxide and angiogenesis. Circulation 
2002;105:2133-5.
54. Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, 
Chilian WM, et al. Angiostatin inhibits coronary angiogenesis during 
impaired production of nitric oxide. Circulation 2002;105:2185-91.
55. Nerkar D, Mukherjee A, Mehta BK, Banerjee S. Metabolic syndrome 
associated complications. Int J Pharm Sci 2015;7:22-5.
56. Ser NA. Flavonoids from Physalis minima. Phytochemistry 
1988;27:3708-9.
57. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, 
van Leeuwen PA, et al. Flavonoids: A review of probable mechanisms 
of action and potential applications. Am J Clin Nutr 2001;74:418-25.
58. Grumbach IM, Chen W, Mertens SA, Harrison DG. A negative 
feedback mechanism involving nitric oxide and nuclear factor kappa-B 
modulates endothelial nitric oxide synthase transcription. J Mol Cell 
Cardiol 2005;39:595-603.
59. Giani JF, Muñoz MC, Pons RA, Cao G, Toblli JE, Turyn D, et al. 
Angiotensin-(1-7) reduces proteinuria and diminishes structural 
damage in renal tissue of stroke-prone spontaneously hypertensive rats. 
Am J Physiol Renal Physiol 2011;300:F272-82.
60. Shen YH, Wang XL, Wilcken DE. Nitric oxide induces and inhibits 
apoptosis through different pathways. FEBS Lett 1998;433:125-31.
61. Stefanec T. Endothelial apoptosis. Chest 2000;117:841-54.
62. Hattori Y, Kasai K, Gross SS. NO suppresses while peroxynitrite 
sustains NF-kappaB: A paradigm to rationalize cytoprotective and 
cytotoxic actions attributed to NO. Cardiovasc Res 2004;63:31-40.
63. Clancy RM, Gomez PF, Abramson SB. Nitric oxide sustains nuclear 
factor kappaB activation in cytokine-stimulated chondrocytes. 
Osteoarthritis Cartilage 2004;12:552-8.
64. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, 
et al. Interstitial vascular rarefaction and reduced VEGF-A expression in 
human diabetic nephropathy. J Am Soc Nephrol 2007;18:1765-76.
65. Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, et al. 
Oxidative stress, prooxidants, and antioxidants: The interplay. Biomed 
Res Int 2014;2014:19.
66. Bouayed J, Bohn T. Exogenous antioxidants-double-edged swords 
in cellular redox state: Health beneficial effects at physiologic doses 
versus deleterious effects at high doses. Oxid Med Cell Longev 
2010;3:228-37.
67. Nnamani C, Ani O, Belunwu G. Larvicidal effects of ethanol extracts 
on leaves and fruits of Physalis angulata L. on the larvae of anopheles 
mosquitoes from Ebonyi state, Nigeria, Anim Res Int 2010;6:1059-62.
68. Shou Y, Gunasekar PG, Borowitz JL, Isom GE. Cyanide-induced 
apoptosis involves oxidative-stress-activated NF-kappaB in cortical 
neurons. Toxicol Appl Pharmacol 2000;164:196-205.
69. Prabhakaran K, Li L, Borowitz JL, Isom GE. Cyanide induces different 
modes of death in cortical and mesencephalon cells. J Pharmacol Exp 
Ther 2002;303:510-9.
